Securian Asset Management Inc. Lowers Position in Silicon Laboratories Inc. (NASDAQ:SLAB)

Securian Asset Management Inc. decreased its position in Silicon Laboratories Inc. (NASDAQ:SLAB) by 4.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,398 shares of the semiconductor company’s stock after selling 100 shares during the period. Securian Asset Management Inc.’s holdings in Silicon Laboratories were worth $298,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Jones Financial Companies Lllp boosted its holdings in Silicon Laboratories by 44.5% during the fourth quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company’s stock worth $28,000 after buying an additional 69 shares in the last quarter. Advisors Asset Management Inc. boosted its holdings in Silicon Laboratories by 159.4% during the third quarter. Advisors Asset Management Inc. now owns 275 shares of the semiconductor company’s stock worth $32,000 after buying an additional 169 shares in the last quarter. Venturi Wealth Management LLC boosted its holdings in Silicon Laboratories by 207.0% during the fourth quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company’s stock worth $98,000 after buying an additional 530 shares in the last quarter. Asset Management One Co. Ltd. purchased a new stake in Silicon Laboratories during the fourth quarter worth about $117,000. Finally, KBC Group NV boosted its holdings in Silicon Laboratories by 42.1% during the fourth quarter. KBC Group NV now owns 1,279 shares of the semiconductor company’s stock worth $159,000 after buying an additional 379 shares in the last quarter.

Insider Buying and Selling

In related news, Director Navdeep S. Sooch sold 2,360 shares of the company’s stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total transaction of $351,640.00. Following the completion of the transaction, the director now owns 400,567 shares of the company’s stock, valued at approximately $59,684,483. This represents a 0.59 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director William G. Bock sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total transaction of $281,540.00. Following the transaction, the director now directly owns 32,115 shares of the company’s stock, valued at $4,520,828.55. This trade represents a 5.86 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 5,360 shares of company stock valued at $782,610. Insiders own 1.72% of the company’s stock.

Silicon Laboratories Price Performance

NASDAQ:SLAB opened at $125.24 on Wednesday. The firm has a 50 day simple moving average of $138.33 and a 200-day simple moving average of $122.98. The firm has a market cap of $4.07 billion, a PE ratio of -21.08 and a beta of 1.15. Silicon Laboratories Inc. has a 1-year low of $94.00 and a 1-year high of $160.00.

Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings data on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.11). Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The business had revenue of $166.25 million during the quarter, compared to analyst estimates of $166.09 million. During the same quarter in the previous year, the business posted ($1.19) earnings per share. The company’s revenue was up 91.4% on a year-over-year basis. As a group, sell-side analysts expect that Silicon Laboratories Inc. will post -0.97 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently commented on SLAB. Barclays boosted their price objective on shares of Silicon Laboratories from $75.00 to $120.00 and gave the stock an “equal weight” rating in a report on Friday, January 17th. Benchmark restated a “buy” rating and set a $160.00 target price on shares of Silicon Laboratories in a research report on Wednesday, March 12th. StockNews.com upgraded shares of Silicon Laboratories from a “sell” rating to a “hold” rating in a research report on Tuesday. Susquehanna began coverage on shares of Silicon Laboratories in a research report on Tuesday, December 17th. They set a “neutral” rating and a $130.00 target price for the company. Finally, Stifel Nicolaus lifted their target price on shares of Silicon Laboratories from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Monday, January 6th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $136.20.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.